- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Thulium fibre laser superior to holmium: YAG for clearing kidney stones: Study
Norway: A new study published in European Urology found that by utilizing thulium fiber laser (TFL) instead of Holmium: yttrium-aluminum-garnet (Ho: YAG), considerably more patients with kidney stones attained the stone-free status and reported fewer intraoperative problems.
The gold standard for ureterorenoscopic (URS) lithotripsy is the Ho: YAG laser. Due to favorable qualities exhibited in preclinical research, thulium fibre laser has recently been offered as a novel technology that may challenge Ho: YAG as the favored laser. This research was carried out by Oyvind Ulvik and his team. assess and compare results following URS lithotripsy with Ho: YAG and TFL.
Patients aged 18 years and older with ureteral and/or renal stones (5 mm) scheduled for day-case URS lithotripsy were asked to participate in this prospective randomized experiment. A total of 120 consecutively hospitalized patients with signed consent were included in the study for randomization. This research included people who had received URS lithotripsy with Ho: YAG or TFL. At the 3-month follow-up, the primary outcome was the stone-free rate (SFR) as determined by non-contrast computed tomography. The operation time and complications were secondary outcomes. The t-test and the 2 tests were used to compare outcomes between groups.
The findings of this article were as follows:
1. SFR was 67% in the Ho: YAG group and 92% in the TFL group after a single session.
2. SFR was 100% in both groups for ureteral stones, 49% (Ho: YAG), and 86% (TFL) for renal stones.
3. TFL required less time to do the procedure (49 minutes) than Ho: YAG (57 minutes).
4. The most common intraoperative adverse event was bleeding that obstructed the endoscopic image, which occurred in 13 patients (22%) in the Ho: YAG group and three (5%) in the TFL group.
In conclusion, this study found that using TFL for stone lithotripsy resulted in improved outcomes and fewer problems, particularly for renal stones.
Reference: Thulium Fibre Laser versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial. Ulvik, Øyvind et al. European Urology. DOI:https://doi.org/10.1016/j.eururo.2022.02.027
Keywords: thulium fibre laser, lithotripsy, holmium, kidney stones, endoscopy, ureter, nephrology, urology, bladder, calcification, European Urology, Oyvind Ulvik
Medical Dialogues consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751